RedTram News Search Engine
Русский  English Українська  Français  Polski  Deutsch  Italiano  Español  中文   
26 October 2009 year (time zone GMT 00:00)  Number of sources in English: 4957
Navigating the themes
Navigating the regions
All Themes Health & Beauty Oncology World
Oncology (World) RSS 2.0

Mayo Researchers Find Few Side Effects From Radiation Treatment Given After Prostate Cancer Surgery

26.10.2009 17:15    cancercompass.com
The largest single-institution study of its kind has found few complications in prostate cancer patients treated with radiotherapy after surgery to remove the prostate. Men in this study received radiotherapy after a prostate-specific antigen (PSA) test following surgery indicated their
Mayo Researchers Find Few Side Effects From Radiation Treatment Given After Prostate Cancer Surgery


PMH Clinicians Map Group At High Risk For Aggressive, 'Hidden' Prostate Cancer

26.10.2009 17:15    cancercompass.com
Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians - why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive
PMH Clinicians Map Group At High Risk For Aggressive, 'Hidden' Prostate Cancer

Scientists At University Hospital Target Prostate Cancer

26.10.2009 17:15    cancercompass.com
According to recent research published in the journal Cancer Epidemiology Biomarkers & Prevention, Genetic predisposition to prostate cancer includes multiple common variants with a low penetrance (single nucleotide polymorphisms) and rare variants with higher penetrance. The mismatch repair (MMR) genes
Scientists At University Hospital Target Prostate Cancer

SRI International Awarded A Department Of Defense 'Laboratory-Clinical Transition' Grant To Advance SRI's Novel Anticancer Agents For Prostate Cancer Treatment

26.10.2009 17:14    cancercompass.com
SRI International, an independent, nonprofit research and development organization, announced that it has been awarded a $1.55M U.S. Department of Defense/Prostate Cancer Research Program (DoD/PCRP) grant to support product- driven, preclinical studies of SRI's novel agents that have the potential
SRI International Awarded A Department Of Defense 'Laboratory-Clinical Transition' Grant To Advance SRI's Novel Anticancer Agents For Prostate Cancer Treatment


University of Virginia Researchers Develop Breakthrough Method That Could Eliminate Trial and Error Aspect of Many Cancer Treatments

26.10.2009 17:14    cancercompass.com
Cancer patients don't have time to waste, yet many must endure a tedious process of elimination as physicians try several different treatments until identifying the one that is most effective against their particular type of tumor. Now researchers at the
University of Virginia Researchers Develop Breakthrough Method That Could Eliminate Trial and Error Aspect of Many Cancer Treatments

Although More Older Women Receive Breast-Conserving Therapy, Gaps In Treatment Exist

26.10.2009 17:14    cancercompass.com
According to a new study published in the October issue of the Journal of the American College of Surgeons, although breast-conserving surgery (BCS), commonly known as lumpectomy, is increasingly being used to treat older women with nonmetastatic invasive breast cancer,
Although More Older Women Receive Breast-Conserving Therapy, Gaps In Treatment Exist

New Non-Small Cell Lung Cancer Research Reported From Harvard University

26.10.2009 17:14    cancercompass.com
According to recent research published in the journal Chest, Non-small cell lung cancer (NSCLC) staging is currently being revised by the International Association for the Study of Lung Cancer (USLC). Among other changes, the revised staging system proposes the subdivision
New Non-Small Cell Lung Cancer Research Reported From Harvard University

Findings In Breast Cancer Reported From Arizona State University

26.10.2009 17:14    cancercompass.com
According to recent research from the United States, The purpose of this study was to determine if breast cancer survivors (BCS) with insomnia can be grouped according to their level of fatigue. A secondary data analysis was conducted on baseline
Findings In Breast Cancer Reported From Arizona State University

Top Community Medical Experts In Breast Cancer, Depression, COPD, Osteoarthritis Highlighted In First-Of-Its-Kind Public Database

26.10.2009 17:14    cancercompass.com
Patients diagnosed with breast cancer or depression who are seeking a medical expert in their own community to guide them through treatment now have a place to start. Qforma, an advanced analytics and predictive modeling company, today introduced the new
Top Community Medical Experts In Breast Cancer, Depression, COPD, Osteoarthritis Highlighted In First-Of-Its-Kind Public Database

Breast Tenderness During Hormone Replacement Therapy Linked To Elevated Cancer Risk

26.10.2009 17:14    cancercompass.com
Women who developed new-onset breast tenderness after starting estrogen plus progestin hormone replacement therapy were at significantly higher risk for developing breast cancer than women on the combination therapy who didn't experience such tenderness, according to a new UCLA study.

Study Finds No Relationship Between PCR Rate And Race In Women With Breast Cancer

26.10.2009 17:13    cancercompass.com
Locally advanced breast cancer patients who received the same class of neoadjuvant chemotherapy were found to have no evidence of disease at the time of their surgery, or achieved pathological complete response, at the same rate regardless of race, according
Study Finds No Relationship Between PCR Rate And Race In Women With Breast Cancer

Study Suggests Mastectomy Not Being Overused For Breast Cancer Treatment

26.10.2009 17:13    cancercompass.com
With there being a concern that mastectomy is excessively used as a treatment for breast cancer, a survey of nearly 2,000 women indicates that breast-conserving surgery was attempted as the initial therapy for about 75 percent of those surveyed, according
Study Suggests Mastectomy Not Being Overused For Breast Cancer Treatment

Data On Breast Cancer Published By Researchers At University Of London

26.10.2009 17:13    cancercompass.com
According to a study from London, the United Kingdom, The relationship between solar exposure or dietary vitamin D intake and breast cancer risk has not been fully elucidated. These associations were studied within the Women's Lifestyle and Health Cohort Study,
Data On Breast Cancer Published By Researchers At University Of London

Surviving Breast Cancer -- Low-Income Females Worst Hit

26.10.2009 17:13    cancercompass.com
Later diagnosis, less first-course treatment and race are the main reasons for the difference in mortality between rich and poor breast cancer patients. A new study, published in the open access journal BMC Cancer, suggests that targeted interventions to increase
Surviving Breast Cancer -- Low-Income Females Worst Hit

Increased Levels Of Mullerian-Inhibiting Substance Could Mean Greater Breast Cancer Risk

26.10.2009 17:12    cancercompass.com
Women with increased levels of Mullerian inhibiting substance (MIS), best known for regulating in utero sexual differentiation in boys, may be at a greater risk for breast cancer.

Women With Breast Cancer Have Low Vitamin D Levels

26.10.2009 17:12    cancercompass.com
Women with breast cancer should be given high doses of vitamin D because a majority of them are likely to have low levels of vitamin D, which could contribute to decreased bone mass and greater risk of fractures, according to
Women With Breast Cancer Have Low Vitamin D Levels

Gene Blamed For Immunological Disorders Shown To Protect Against Breast Cancer Development

26.10.2009 17:12    cancercompass.com
Researchers at Georgetown University Medical Center (GUMC) are voicing alarm that drugs to treat a wide variety of allergies, asthma and autoimmune diseases now in human clinical trials may errantly spur development of breast tumors.
Gene Blamed For Immunological Disorders Shown To Protect Against Breast Cancer Development

Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for FUSILEV in Advanced Metastatic Colorectal Cancer

26.10.2009 17:12    cancercompass.com
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for FUSILEV in Advanced Metastatic Colorectal Cancer

Research from University of Colorado, Medical Department has provided new information about colon cancer

26.10.2009 17:12    cancercompass.com
According to recent research from the United States, Despite effective prevention and early detection screening methods, colorectal cancer is the second leading cause of cancer death in the United States. Colorectal cancer screening community-based interventions are rare, and the literature
Research from University of Colorado, Medical Department has provided new information about colon cancer

1